Status:

COMPLETED

A Study For Using Radiosurgery On Limited Metastases

Lead Sponsor:

University of Rochester

Conditions:

Neoplasms, Metastatic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The standard therapy in cases such as yours is surgery, radiation therapy, chemotherapy or hormonal therapy alone or in combination. The main purpose of this study is to evaluate whether radiosurgery ...

Detailed Description

In this research study high dose stereotactic body radiation therapy will be directed at the site of metastasis. This treatment will be given once a day, 5 times a week (Monday through Friday) for one...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • KPS ≥ 70
  • Palliative: Disease most likely to be life limiting, is definable, and treatable to a sterilizing dose according to protocol criteria.
  • The size of the lesion must be such that it can be safely treated to sterilizing radiation doses according to the rules in the protocol
  • Previously treated lesions are not eligible unless the prescribed dose can be safely delivered. Previously enrolled patients can be retreated to new lesions if they still meet protocol requirements.
  • Informed consent must be obtained.
  • Pregnancy test must be negative for women of child bearing potential.
  • Out of state patients are eligible, if communication with the referring physicians is expected to be adequate to address the primary aim. The secondary aim (blood cytokines) is optional for out-of-state patients.

Exclusion

  • Technical inability to achieve required dose based on safe dose constraints required for radiosurgery
  • Women who are pregnant or nursing..
  • Failure to meet inclusion requirements
  • Contraindications to radiation.
  • Patient should not be eligible for primary disease specific radiosurgical protocols

Key Trial Info

Start Date :

April 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2007

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT00178399

Start Date

April 1 2001

End Date

March 15 2007

Last Update

October 11 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester Department of Radiation Oncology

Rochester, New York, United States, 14642